New platform aims to better characterize tumor cell populations that survive therapy and drive cancer relapseDALLAS--(BUSINESS WIRE)--SingleCell Biotechnology, a biotechnology company developing ...
Preclinical data demonstrate how Soley’s proprietary drug discovery platform translates cell stress biology into first-in-class drug candidatesSOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
A research team, affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results